For these reasons, the aim of our meta-analysis was to investigate whether circulating Nrg4 levels were associated with DM and clinical indices of diabetes, renal function, metabolic syndrome and obesity in diabetes patients. Here, NRG4 is linked to obesity due to melanocortin 4 receptor deficiency.